Progenics Pharmaceuticals (PGNX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | PGNX | AGN | MYL | TEVA | RDY |
| Company | Progenics Pharmaceuticals | Allergan Plc | Mylan NV Ord Shs | Teva Pharmaceutical Industries ADR | Dr. Reddy's Laboratories Ltd ADR |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NYSE | NYSE |
| Open | 4.60 | 193.01 | 15.64 | 12.98 | 71.43 |
| High | 4.79 | 193.38 | 16.15 | 13.09 | 71.63 |
| Low | 3.94 | 191.64 | 15.34 | 12.86 | 70.78 |
| Last | 4.10 | 193.02 | 15.86 | 13.01 | 70.92 |
| Change | -0.43 | +0.03 | +0.31 | unch | -0.57 |
| % Change | -9.39% | +0.02% | +1.96% | unch | -0.80% |
| Volume | 34,928,300 | 12,442,600 | 26,574,100 | 7,499,700 | 149,200 |
| 20-Day Average Volume | 2,569,575 | 4,993,145 | 8,612,350 | 9,029,814 | 163,055 |
| Previous Close | 4.53 | 192.99 | 15.55 | 13.01 | 71.49 |
| Industry | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs |
| Has Options | No | No | No | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 4.30 | 188.05 | 15.15 | 13.59 | 72.40 |
| 20-Day Raw Stochastic | 31.13% | 76.90% | 86.27% | 25.58% | 5.50% |
| 20-Day Relative Strength | 49.46% | 59.14% | 55.75% | 44.99% | 41.34% |
| Weighted Alpha | -27.10 | +28.20 | -23.10 | +54.76 | +15.01 |
| Today's Opinion | 8% Sell | 72% Buy | 40% Sell | 56% Buy | 24% Buy |
| Previous Opinion | 16% Buy | 56% Buy | 64% Sell | 56% Buy | 24% Buy |
| Last Month's Opinion | 72% Sell | 24% Sell | 64% Sell | 100% Buy | 56% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.49% since 06/12/20 | +1.73% since 05/01/20 | +4.86% since 11/09/20 | -1.29% since 04/17/24 | -0.55% since 04/17/24 |
| Low | 3.86 on 06/15/20 | 187.75 on 05/04/20 | 15.10 on 11/10/20 | 12.51 on 04/19/24 | 70.71 on 04/19/24 |
| High | 4.79 on 06/19/20 | 196.45 on 05/06/20 | 16.15 on 11/16/20 | 13.21 on 04/18/24 | 72.23 on 04/22/24 |
| 1-Month | |||||
| %Chg | +12.95% since 05/19/20 | +6.59% since 04/08/20 | +0.92% since 10/16/20 | -6.34% since 03/22/24 | -3.48% since 03/22/24 |
| Low | 3.72 on 05/20/20 | 181.21 on 04/09/20 | 14.00 on 10/29/20 | 12.51 on 04/19/24 | 70.71 on 04/19/24 |
| High | 4.83 on 06/08/20 | 196.45 on 05/06/20 | 16.15 on 11/16/20 | 14.47 on 04/08/24 | 74.44 on 04/01/24 |
| 3-Month | |||||
| %Chg | +94.31% since 03/19/20 | -2.05% since 02/07/20 | -2.07% since 08/14/20 | +8.69% since 01/24/24 | +0.82% since 01/24/24 |
| Low | 2.05 on 03/20/20 | 158.67 on 03/18/20 | 14.00 on 10/29/20 | 11.48 on 01/30/24 | 69.18 on 01/25/24 |
| High | 4.83 on 06/08/20 | 202.21 on 02/12/20 | 17.03 on 08/19/20 | 14.47 on 04/08/24 | 77.72 on 02/23/24 |
| 6-Month | |||||
| %Chg | -21.76% since 12/19/19 | +6.48% since 11/08/19 | +4.58% since 05/15/20 | +58.85% since 10/24/23 | +6.20% since 10/24/23 |
| Low | 1.89 on 03/19/20 | 158.67 on 03/18/20 | 14.00 on 10/29/20 | 8.10 on 10/27/23 | 63.72 on 11/03/23 |
| High | 6.37 on 12/23/19 | 202.21 on 02/12/20 | 19.24 on 06/08/20 | 14.47 on 04/08/24 | 77.72 on 02/23/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 355,048 | 63,503,972 | 8,586,212 | 14,585,432 | 11,930,109 |
| Shares Outstanding, K | 86,597 | 329,002 | 541,546 | 1,121,094 | 166,878 |
| Annual Sales | 34,990,000 | 16,088,900,000 | 11,500,500,000 | 15,846,000,000 | 2,992,000,000 |
| Annual Net Income | -68,550,000 | -5,271,000,000 | 16,800,000 | -559,000,000 | 548,000,000 |
| Last Quarter Sales | 6,250,000 | 4,351,000,000 | 2,972,100,000 | 4,457,000,000 | 865,780,000 |
| Last Quarter Net Income | -16,800,000 | -317,200,000 | 185,700,000 | 429,000,000 | 165,470,000 |
| 60-Month Beta | 1.89 | 1.20 | 1.45 | 1.05 | 0.58 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 5.22 on 02/10/20 | 0.36 on 11/06/20 | 1.00 on 01/31/24 | 0.99 on 01/31/24 |
| Latest Earnings Date | 08/14/20 | 05/07/20 | 11/06/20 | 05/08/24 | 05/08/24 |
| Most Recent Dividend | N/A | 0.740 on 04/15/20 | 0.060 on 06/27/07 | 0.072 on 11/27/17 | 0.410 on 07/28/23 |
| Next Ex-Dividends Date | N/A | 04/15/20 | N/A | 11/27/17 | 07/28/23 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 10.94 | 3.29 | 5.21 | 19.04 |